Aclarion, Inc., (“Aclarion” or the “Company”) (Nasdaq: ACON, ACONW), a healthcare technology company that is leveraging biomarkers and proprietary augmented intelligence (AI) algorithms to help ...

Aclarion (ACON) announced plans to expand Nociscan access across key markets in New York and New Jersey. The expansion plans build on previously established Nociscan sites with RadNet (RDNT) ...

Detailed price information for Aclarion Inc WT (ACONW-Q) from The Globe and Mail including charting and trades.

Inc trading halted, volatility trading pauseDiscover the Best Stocks and Maximize Your Portfolio: See what stocks are ...

Inc trading resumesDiscover the Best Stocks and Maximize Your Portfolio: See what stocks are receiving Strong Buy ...

BROOMFIELD, Colo. - Aclarion, Inc. (NASDAQ: ACON, ACONW), a healthcare technology company specializing in chronic low back pain diagnosis, with a current market capitalization of $7.11 million ...

Aclarion, Inc., a healthcare technology company specializing in chronic low back pain solutions, announced plans to expand access to its Nociscan service in New York and New Jersey, building on ...

BROOMFIELD, Colo., March 06, 2025 (GLOBE NEWSWIRE) -- Aclarion, Inc., (“Aclarion” or the “Company”) (Nasdaq: ACON, ACONW), a healthcare technology company ...

Agreement expands access to Nociscan technology for leading spine physicians and more than 3.2M people in the greater San Diego Metro area Nociscan leverages MR Spectroscopy (MRS) and Augmented ...

PALM BEACH, Fla., March 10, 2025 (GLOBE NEWSWIRE) -- FN media Group News Commentary - A report from Fortune Business Insights said that the global artificial intelligence in healthcare market size is ...